Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-25 @ 7:04 PM
Study NCT ID:
NCT01254604
Status:
COMPLETED
Last Update Posted:
2018-09-20
First Post:
2010-12-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2013-05-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-03
First Submit QC Date:
None
Study First Post Date:
2010-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-09
Results First Submit QC Date:
None
Results First Post Date:
2014-05-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-21
Last Update Post Date:
2018-09-20
Last Update Post Date Type:
ACTUAL